This study provides an in-depth understanding on the modulation of RNF6 auto-ubiquitination and initiated the concept that chemical induction of auto-ubiquitination represents a novel strategy for the treatment of leukemia and myeloma. Here, RNF6 is linked to plasma cell myeloma.